- Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024 | M CDC
- RSV shot for infants 90 percent effective against hospitalizations: CDC The Hill
- CDC says new treatment for infant RSV infections ‘highly effective’ in preventing hospitalization WSB Atlanta
- Only nine percent of older Americans were vaccinated against RSV before the disease hit this fall and winter Medical Xpress
- RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC STAT
You can read the full story here: Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants .